Targocid 400 mg or. sol. (pwdr. + solv.)/inj. sol. (pwdr. + solv.)/inf. sol. (pwdr. + solv.) i.v./i.m. vial

Nazione: Belgio

Lingua: inglese

Fonte: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Principio attivo:

Teicoplanin 400 mg

Commercializzato da:

Sanofi Belgium SA-NV

Codice ATC:

J01XA02

INN (Nome Internazionale):

Teicoplanin

Dosaggio:

400 mg

Forma farmaceutica:

Powder and solvent for solution for injection; Powder and solvent for solution for infusion; Powder and solvent for oral solution

Composizione:

Teicoplanin 400 mg

Via di somministrazione:

Intramuscular use; Intravenous use; Oral use

Area terapeutica:

Teicoplanin

Dettagli prodotto:

CTI code: 147034-04 - Pack size: 25 x 400 mg + 25 x 3 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 147034-01 - Pack size: 400 mg + 3 ml - Commercialisation status: YES - FMD code: 03582910086536 - CNK code: 0489203 - Delivery mode: Medical prescription; CTI code: 147034-02 - Pack size: 5 x 400 mg + 5 x 3 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 147034-03 - Pack size: 10 x 400 mg + 10 x 3 ml - Commercialisation status: NO - Delivery mode: Medical prescription

Stato dell'autorizzazione:

Commercialised: Yes

Data dell'autorizzazione:

1989-03-08